1. Home
  2. COLL vs ARI Comparison

COLL vs ARI Comparison

Compare COLL & ARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$48.66

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Apollo Commercial Real Estate Finance Inc

ARI

Apollo Commercial Real Estate Finance Inc

HOLD

Current Price

$9.96

Market Cap

1.4B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
COLL
ARI
Founded
2002
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2015
2009

Fundamental Metrics

Financial Performance
Metric
COLL
ARI
Price
$48.66
$9.96
Analyst Decision
Strong Buy
Buy
Analyst Count
6
4
Target Price
$47.50
$10.83
AVG Volume (30 Days)
494.7K
1.1M
Earning Date
02-26-2026
02-09-2026
Dividend Yield
N/A
10.25%
EPS Growth
N/A
N/A
EPS
1.63
0.89
Revenue
$757,067,000.00
$269,296,000.00
Revenue This Year
$26.35
$25.91
Revenue Next Year
$3.67
$14.63
P/E Ratio
$29.06
$11.00
Revenue Growth
26.34
67.16
52 Week Low
$23.23
$7.70
52 Week High
$50.79
$11.11

Technical Indicators

Market Signals
Indicator
COLL
ARI
Relative Strength Index (RSI) 58.37 50.34
Support Level $44.51 $9.64
Resistance Level $50.79 $9.93
Average True Range (ATR) 1.45 0.17
MACD -0.40 -0.01
Stochastic Oscillator 63.89 61.22

Price Performance

Historical Comparison
COLL
ARI

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About ARI Apollo Commercial Real Estate Finance Inc

Apollo Commercial Real Estate Finance Inc is a real estate investment trust that primarily originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.

Share on Social Networks: